Impact of uremia on human adipose tissue phenotype

Journal of Surgical Research

Volumn 179, Issue 1, 2013, Pages 175-182

  Ho, Karen J ^a   Xue, Hui ^a   Mauro, Christine R ^a   Nguyen, Binh ^a   Yu, Peng ^a   Tao, Ming ^a   Seidman, Michael A ^a   Brunelli, Steven M ^a   Ozaki, Charles Keith ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adiponectin; Adipose tissue; Chronic kidney disease; Leptin; Resistin; Uremia

Indexed keywords

ADIPONECTIN; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; UREMIA;

ADIPONECTIN; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; KIDNEY; LEPTIN; MALE; MIDDLE AGED; PHENOTYPE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RESISTIN; SUBCUTANEOUS FAT; UREMIA;

EID: 84870686679     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.08.043     Document Type: Article

References (44)

1. G.N. Chaldakov, I.S. Stankulov, M. Hristova, and P.I. Ghenev Adipobiology of disease: adipokines and adipokine-targeted pharmacology Curr Pharm Des 9 2003 1023
2. K. Sun, C.M. Kusminski, and P.E. Scherer Adipose tissue remodeling and obesity J Clin Invest 121 2011 2094
3. S. Galic, J.S. Oakhill, and G.R. Steinberg Adipose tissue as an endocrine organ Mol Cell Endocrinol 316 2010 129
4. M. Bluher The distinction of metabolically 'healthy' from 'unhealthy' obese individuals Curr Opin Lipidol 21 2010 38
5. R.S. Jackson, J.H. Black 3rd, Y.W. Lum, E.B. Schneider, and J.A. Freischlag Class I obesity is paradoxically associated with decreased risk of postoperative stroke after carotid endarterectomy J Vasc Surg 55 2012 1306
6. D. Vela, L.M. Buja, and M. Madjid The role of periadventitial fat in atherosclerosis Arch Pathol Lab Med 131 2007 481
7. T.K. Chatterjee, L.L. Stoll, and G.M. Denning Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding Circ Res 104 2009 541
8. M. Takaoka, H. Suzuki, and S. Shioda Endovascular injury induces rapid phenotypic changes in perivascular adipose tissue Arterioscler Thromb Vasc Biol 30 2010 1576
9. A. Witasp, J.J. Carrero, and O. Heimburger Increased expression of pro-inflammatory genes in abdominal subcutaneous fat in advanced chronic kidney disease patients J Intern Med 269 2011 410
10. V. Teplan Jr., F. Vyhnanek, and R. Gurlich Increased proinflammatory cytokine production in adipose tissue of obese patients with chronic kidney disease Wien Klin Wochenschr 122 2010 466
11. C. Pachler, D. Ikeoka, and J. Plank Subcutaneous adipose tissue exerts proinflammatory cytokines after minimal trauma in humans Am J Physiol Endocrinol Metab 293 2007 E690
12. D.T. Ikeoka, C. Pachler, and J.K. Mader Lipid-heparin infusion suppresses the IL-10 response to trauma in subcutaneous adipose tissue in humans Obesity (Silver Spring) 19 2011 715
13. A.A. Bremer, S. Devaraj, A. Afify, and I. Jialal Adipose tissue dysregulation in patients with metabolic syndrome J Clin Endocrinol Metab 96 2011 E1782
14. R.N. Foley, P.S. Parfrey, and M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32 1998 S112
15. R.N. Foley Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure Semin Dial 16 2003 111
16. C. Baigent, K. Burbury, and D. Wheeler Premature cardiovascular disease in chronic renal failure Lancet 356 2000 147
17. M. Rao, L. Li, H. Tighiouart, B.L. Jaber, B.J. Pereira, V.S. Balakrishnan HEMO Study Group Plasma adiponectin levels and clinical outcomes among haemodialysis patients Nephrol Dial Transplant 23 2008 2619
18. V. Menon, X. Wang, and T. Greene Factors associated with serum leptin in patients with chronic kidney disease Clin Nephrol 61 2004 163
19. J. Malyszko, J.S. Malyszko, P. Kozminski, K. Pawlak, and M. Mysliwiec Elevated resistin is related to inflammation and residual renal function in haemodialysed patients Nephrology (Carlton) 12 2007 246
20. K.D. Nusken, J. Kratzsch, V. Wienholz, W. Stohr, W. Rascher, and J. Dotsch Circulating resistin concentrations in children depend on renal function Nephrol Dial Transplant 21 2006 107
21. S. Pilz, G. Weihrauch, and U. Seelhorst Implications of resistin plasma levels in subjects undergoing coronary angiography Clinical endocrinology 66 2007 380
22. J. Himmelfarb, P. Stenvinkel, T.A. Ikizler, and R.M. Hakim The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia Kidney Int 62 2002 1524
23. M. Arici, and J. Walls End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 59 2001 407
24. R.N. Foley, P.S. Parfrey, and M.J. Sarnak Epidemiology of cardiovascular disease in chronic renal disease J Am Soc Nephrol 9 1998 S16
25. P.A. McCullough, V. Agrawal, E. Danielewicz, and G.S. Abela Accelerated atherosclerotic calcification and Monckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease Clin J Am Soc Nephrol 3 2008 1585
26. S. Swaminathan, and S.V. Shah Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease Kidney Int 80 2011 453
27. A. Lindner, B. Charra, D.J. Sherrard, and B.H. Scribner Accelerated atherosclerosis in prolonged maintenance hemodialysis N Engl J Med 290 1974 697
28. J.J. Snyder, R.N. Foley, D.T. Gilbertson, E.F. Vonesh, and A.J. Collins Body size and outcomes on peritoneal dialysis in the United States Kidney Int 64 2003 1838
29. N. Drey, P. Roderick, M. Mullee, and M. Rogerson A population-based study of the incidence and outcomes of diagnosed chronic kidney disease Am J Kidney Dis 42 2003 677
30. J. Chudek, M. Adamczak, and H. Karkoszka Plasma adiponectin concentration before and after successful kidney transplantation Transplant Proc 35 2003 2186
31. G. Cohen, and W.H. Horl Resistin as a cardiovascular and atherosclerotic risk factor and uremic toxin Semin Dial 22 2009 373
32. J. Hung, B.M. McQuillan, P.L. Thompson, and J.P. Beilby Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity Int J Obes (Lond) 32 2008 772
33. H. Bays, N. Abate, and M. Chandalia Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia Future Cardiol 1 2005 39
34. H.E. Bays Adiposopathy is "sick fat" a cardiovascular disease? J Am Coll Cardiol 57 2011 2461
35. F. Cumin, H.P. Baum, M. de Gasparo, and N. Levens Removal of endogenous leptin from the circulation by the kidney Int J Obes Relat Metab Disord 21 1997 495
36. R.H. Mak, W. Cheung, R.D. Cone, and D.L. Marks Leptin and inflammation-associated cachexia in chronic kidney disease Kidney international 69 2006 794
37. W. Cheung, P.X. Yu, B.M. Little, R.D. Cone, D.L. Marks, and R.H. Mak Role of leptin and melanocortin signaling in uremia-associated cachexia J Clin Invest 115 2005 1659
38. J.T. Kielstein, B. Becker, S. Graf, G. Brabant, H. Haller, and D. Fliser Increased resistin blood levels are not associated with insulin resistance in patients with renal disease Am J Kidney Dis 42 2003 62
39. A.M. Wallace, A.D. McMahon, and C.J. Packard Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS) Circulation 104 2001 3052
40. K. Matsushita, H. Yatsuya, and K. Tamakoshi Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men Arterioscler Thromb Vasc Biol 26 2006 871
41. T. Pischon, C.J. Girman, G.S. Hotamisligil, N. Rifai, F.B. Hu, and E.B. Rimm Plasma adiponectin levels and risk of myocardial infarction in men JAMA 291 2004 1730
42. M.B. Schulze, I. Shai, E.B. Rimm, T. Li, N. Rifai, and F.B. Hu Adiponectin and future coronary heart disease events among men with type 2 diabetes Diabetes 54 2005 534
43. E. Cavusoglu, C. Ruwende, and V. Chopra Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain Eur Heart J 27 2006 2300
44. S. Pilz, H. Mangge, and B. Wellnitz Adiponectin and mortality in patients undergoing coronary angiography J Clin Endocrinol Metab 91 2006 4277